Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_assertion type Assertion NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_head.
- NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_assertion description "[Logistic regression analysis revealed that concomitant expression of stromelysin 3 and Ets-1 (stromelysin 3(+)/ Ets-1(+) phenotype; odds ratio, 3.7; P = 0.001) was the most significant predictor for transition to precancerous stage, whereas dual expression of stromelysin 3 and VEGF (stromelysin 3(+)/ VEGF(+) phenotype; odds ratio, 2.07; P = 0.004) was the most important predictor for progression from precancerous stage to frank malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_provenance.
- NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_assertion evidence source_evidence_literature NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_provenance.
- NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_assertion SIO_000772 15788677 NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_provenance.
- NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_assertion wasDerivedFrom befree-20150227 NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_provenance.
- NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_assertion wasGeneratedBy ECO_0000203 NP565338.RAlNkMswC1aorCjF5Wx-hKNOTrzKFieIXfcBsfVM0gJ2A130_provenance.